Davidson Kempner Capital Management’s Amedisys AMED Stock Holding History

Davidson Kempner Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-492,992	Closed	-$48.5M	–	237
2025 Q2	$48.5M	Sell	492,992 -662,238	-57%	-$62.7M	0.7%	38
2025 Q1	$107M	Buy	1,155,230 +293,658	+34%	+$27.1M	1.47%	11
2024 Q4	$78.2M	Buy	861,572 +696,777	+423%	+$64M	1.31%	17
2024 Q3	$15.9M	Buy	164,795 +80,857	+96%	+$7.89M	0.33%	80
2024 Q2	$7.7M	Buy	+83,938	New	+$7.79M	0.12%	131
2023 Q4	–	Sell	-326,752	Closed	-$30.5M	–	248
2023 Q3	$30.5M	Buy	+326,752	New	+$30.2M	0.4%	52

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Davidson Kempner Capital Management's AMED Position: Q3 2025 in Review

Davidson Kempner Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 492,992 shares — an estimated $48.5M sold.

Davidson Kempner Capital Management first reported a position in AMED in Q3 2023 and held it in 6 quarters. The position peaked at $107M in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Davidson Kempner Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Davidson Kempner Capital Management sold 492,992 Amedisys shares in Q3 2025, an estimated $48.5M.
Davidson Kempner Capital Management first reported a position in Amedisys in Q3 2023 and held it in 6 quarters.
Davidson Kempner Capital Management's Amedisys position peaked at $107M in Q1 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.